Table 2.
Treatment results of endoscopic submucosal dissection for gastric tube cancer and histopathological findings
Lesions, n
|
48
|
Median procedure time, min (range) | 81 (29-334) |
En bloc resection, n (%) | 44 (91.7) |
Adverse events during ESD, n (%) | |
Bleeding | 1(2) |
Perforation | 1(2) |
Adverse events post ESD, n (%) | |
Bleeding | 2 (4) |
Subcutaneous abscess | 1 (2) |
Liver failure | 1 (2) |
Respiratory failure | 1 (2) |
Median tumor size, mm (range) | 15 (4-60) |
Histrogical type, n | |
Differentiated | 43 |
Undifferentiated | 5 |
Tumor depth, n | |
M | 40 |
SM1 | 4 |
SM2 | 4 |
Ulcerative findings, n | |
Absent | 41 |
Present | 7 |
Lymphatic infiltration, n | |
Negative | 3 |
Positive | 45 |
Lymphatic infiltration, n | |
Negative | 1 |
Positive | 47 |
Horizontal margin, n | |
Negative | 45 |
Positive | 3 |
Vertical margin, n | |
Negative | 47 |
Positive | 1 |
eCura, n (%) | |
A | 38 (79) |
C-1 | 3 (6) |
C-2 | 7 (15) |
ESD: Endoscopic submucosal dissection; M: Intramucosal; SM1: Submucosal superficial; SM2: Submucosal deep invasive.